NovoCure Ltd - Company Profile
Powered by
All the data and insights you need on NovoCure Ltd in one report.
- Save hours of research time and resources with
our up-to-date NovoCure Ltd Strategy Report
- Understand NovoCure Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
NovoCure Ltd (NovoCure) discovers, develops and markets novel Tumor Treating Fields (TTF) delivery systems for the treatment of aggressive cancer of brain and abdomen. Proprietary technology, focus on innovation, and presence in major geographical markets are its strengths, even as reliance on third-party manufacturers and a history of operating loss could be causes for concern to the company. NovoCure could benefit from the growing market for pancreatic cancer, unmet medical needs of GBM and malignant pleural mesothelioma potential (MPM), and strategic agreements. However, rapid technological changes, regulatory oversight, and requirements of payors could affect its operational and financial growth.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer